zpharm is the maker of Cravv® – for smoking cessation. Cravv® is a new, “first of its kind in Canada”, natural health product designed to help reduce nicotine cravings in smokers, making it easier to quit for good.
The product’s main ingredient, cytisine, is an alkaloid that occurs naturally in several plant species and helps to block the receptors that recognize nicotine. In a trial published in the New England Journal of Medicine, cytisine was shown to be more efficacious than nicotine replacement therapy (NRT) in helping smokers quit smoking.
Available online and at select Canadian pharmacies. Cravv® targets the 5+ million Canadians – roughly 17% of the country’s population – who remain addicted to the smoking habit.
The brainchild of Waterloo-based health tech startup zpharm, Cravv® was recently approved by Health Canada as a natural health product.
“We are excited to bring Cravv® to those Canadians who have long struggled to quit smoking,” Dr. Blake Ziegler, Adjunct Assistant Professor at the University of Waterloo School of Pharmacy and CEO of zpharm, told us.
“Cytisine has been shown to be safe and efficacious in multiple clinical trials and we believe it represents a very attractive alternative to current therapies for the millions of Canadians who currently smoke tobacco products.”
zpharm develops natural health products with evidence of safety and efficacy in areas of unmet need. A privately held company, zpharm was founded in 2015 by an experienced pharmacist who wanted to bring better treatment options to patients across Canada.
For more information visit www.zpharm.ca to learn about the company.